Susan Veldhof

Abbott (Belgium) — Belgium

Medicine · Health Sciences

36h-index5.9kcitations87works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Coronary Interventions and Diagnostics(81), Cardiac Imaging and Diagnostics(37), Cardiac Valve Diseases and Treatments(32), Cerebrovascular and Carotid Artery Diseases(18), Peripheral Artery Disease Management(14)

Publications87 total

Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation
JACC: Cardiovascular Interventions·2017· 22 citedOpen Access
Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy
European Heart Journal - Cardiovascular Imaging·2017· 16 citedOpen Access
Efficacy and Safety of the AbsorbEverolimus-Eluting BioresorbableScaffold for Treatment ofPatients With Diabetes Mellitus
2017
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus
JACC: Cardiovascular Interventions·2016· 22 cited
Reproducibility of endothelial shear stress and low density lipoprotein transport modeling in computed tomography angiographic imaging data
Atherosclerosis·2016
RELATION BETWEEN BIORESORBABLE SCAFFOLD SIZING USING QCA-DMAX AND CLINICAL OUTCOMES AT 2 YEARS IN 1192 PATIENTS FROM THREE STUDY COHORTS (ABSORB COHORT B, ABSORB EXTEND AND ABSORB II)
Journal of the American College of Cardiology·2016
Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study
European Heart Journal - Cardiovascular Imaging·2016· 55 citedOpen Access
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis
Journal of the American College of Cardiology·2016· 159 citedOpen Access
Edge Vascular Response After Resorption of the Everolimus-Eluting Bioresorbable Vascular Scaffold　– A 5-Year Serial Optical Coherence Tomography Study –
Circulation Journal·2016· 18 citedOpen Access
Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis
Revista Española de Cardiología (English Edition)·2015· 7 citedOpen Access
Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria
Revista Española de Cardiología·2015· 9 cited
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
JACC: Cardiovascular Interventions·2015· 56 citedOpen Access
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data
EuroIntervention·2015· 50 cited
The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stent
European Heart Journal - Quality of Care and Clinical Outcomes·2015· 3 citedOpen Access
TCT-507 Edge Vascular Response After Resorption of Everolimus-Eluting Bioresorbable Vascular Scaffold: A 5-Year Serial Optical Coherence Tomography Study
Journal of the American College of Cardiology·2015· 1 cited
TCT-369 Correlation of Cardiovascular Risk Factors, Angina Patterns and Intravascular Ultrasound Findings: Largest Contemporary Characterization of Target Lesions
Journal of the American College of Cardiology·2015
TCT-368 Natural history of coronary calcification: A 5-year serial optical coherence tomography study
Journal of the American College of Cardiology·2015
TCT-11 Five-year Follow up of the First in Man use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis; A Serial Multi-Imaging Modality Study
Journal of the American College of Cardiology·2015· 2 cited
Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold
JACC: Cardiovascular Interventions·2014· 116 citedOpen Access
Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffold
JACC: Cardiovascular Interventions·2014· 24 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Patrick W. Serruys(41), Yoshinobu Onuma(33), John A. Ormiston(23), Leif Thuesen(21), Héctor M. García‐García(20), Dariusz Dudek(20), Cécile Dorange(19), Robert Whitbourn(19), Bernard Chevalier(17), Dougal McClean(15), Jacques Koolen(15), Richard Rapoza(15), Evelyn Regar(14), Robert‐Jan van Geuns(14), Stephan Windecker(13), Bernard De Bruyne(12), Pieter C. Smits(12), Vasim Farooq(12), Karine Miquel‐Hébert(11), Salvatore Brugaletta(10)